Navigation Links
Coloplast Launches the Innovative Altis Single Incision Sling System
Date:11/13/2012

MINNEAPOLIS, Nov. 13, 2012 /PRNewswire/ -- Coloplast today announced the U.S. launch of its new surgical urology and gynecology medical device, the Altis® Single Incision Sling System (SIS).

Altis received FDA clearance on November 5, 2012, based on Coloplast's submission of an Investigational Device Exemption (IDE) Study, which included implant data. Altis is a unique, minimally invasive sling that combines integrated two-way tensioning with lightweight sling material to provide strength, security and adjustability.

Designed with surgeons to address unmet needs, Altis provides physicians with an innovative adjustability mechanism during implantation and an introducer designed for safe, repeatable anchor placement, avoiding obturator vascular and nerve bundles. The dynamic tensioning system allows for the sling to be intra-operatively adjusted for proper support under the urethra. Altis is made from the lightest, knitted monofilament polypropylene and has low elasticity.

"Listening and responding—to physicians and their patients' needs—is at the heart of Coloplast. It is how we deliver a variety of solutions to physicians to use in their treatment of the intimate health care needs of their patients. Altis is a great example of the innovation enabled by ongoing dialogue; a sling that accommodates individual patient anatomy, provides easier implantation and delivers optimal urethral support," said Eric Halvorson, Global VP of Surgical Urology, Coloplast US.

Minimal Passage Through Skin Aids Physicians
Altis is different from existing products, as it does not require passage through abdominal skin exits for anchoring or tensioning. The elimination of skin exits allows the Altis sling implant to be smaller and the implantation procedure to be streamlined.

Dynamic Anchor Creates Two-Way Adjustability
The Altis sling has two innovative anchors to hold the sling in place during the tissue in-growt
'/>"/>

SOURCE Coloplast
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. First Paralyzed Formula Race Car Drivers "Road to Indy" Sponsored By Coloplast
2. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
3. CareFusion Launches New Preoperative Cleansing Program For In-Home Patient Use
4. AdvaMed Launches MVP Mentoring Portal for Veterans
5. SafeCode Drug Technologies Launches New Website With Product Video Demonstrating the Worlds Next Generation Application for Drug Safety Administration
6. AASLD Curriculum & Training (ACT) Launches With New Interactive HCV Education
7. Sarnova Launches Curaplex Private Label Brand
8. Zimmer Launches Smartphone Comeback App Globally
9. OKI Europe Launches Cost-effective DICOM-embedded LED Printer Range - a First for Medical Imaging and Printing
10. Amdocs Launches Cloud-Based eHealth Solutions to Give Service Providers Fast Entry to Growing Market
11. Eaton Scientific Expands Investor Relations Strategy and Launches Important New Website Content
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today ... June 30, 2014. Financial Results for the Six ... revenue for the quarter ended June 30, 2014 increased to ... 30, 2013 primarily due to IMBRUVICA ® (ibrutinib) net ... for the six months ended June 30, 2014 increased to ...
(Date:7/31/2014)... VIEW, Calif. , July 31, 2014 /PRNewswire/ ... today provided an update on its pipeline and ... 2014, Alexza expects to initiate a Phase 2a ... is being developed for the management of patients ... two new Staccato -based product candidates for ...
(Date:7/31/2014)... , July 31, 2014 Rock Creek Pharmaceuticals, ... it has initiated the development of its lead molecule, ... that it has selected Quotient Clinical, The Translational Pharmaceutics ... (UK) to run its early development programs. ... Application (CTA) by the end of the third quarter ...
Breaking Medicine Technology:Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24Pharmacyclics Reports Second Quarter 2014 Results 25Pharmacyclics Reports Second Quarter 2014 Results 26Pharmacyclics Reports Second Quarter 2014 Results 27Pharmacyclics Reports Second Quarter 2014 Results 28Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 2Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 3Rock Creek Pharmaceuticals Provides Update of its European Drug Development Regulatory Strategy and selects Quotient Clinical for its early development programs 4
... March 30, 2011 Neurocrine Biosciences, Inc. (Nasdaq: ... Executive Officer of Neurocrine Biosciences, will be presenting at the ... The live presentation takes place on Wednesday, ... a.m. Pacific Time.  The presentation will be webcast and may ...
... 2011 CANTEL MEDICAL CORP. (NYSE: ... President, will be presenting at the Needham & Company, LLC ... 4:00 PM EDT on Wednesday, April 6, 2011 at the ... immediately following the presentation.  In addition, Mr. Segel will be ...
Cached Medicine Technology:
(Date:8/1/2014)... -- Almost 140 people die every year in ... States. But there are several simple ways ... prevention coordinator at Cincinnati Children,s Hospital Medical Center,s ... center news release. "As families begin to ... for parents and children to go over school ...
(Date:8/1/2014)... Illinois (PRWEB) August 01, 2014 As ... across the country, Ronald E. Johnson, Jr. has been ... by AndroGel and other testosterone medications. Since the Fall ... Johnson, P.S.C. have worked diligently to investigate and prosecute ... pulmonary embolisms, and blood clots as a result of ...
(Date:8/1/2014)... August 01, 2014 Market Publishers ... reports have been added to its catalogue. ... Pharmaceutical Ingredients (APIs), Contract Research and Manufacturing Services ... pharma industry drivers include, among others, increasing ageing ... hygiene. In 2015, the pharma market in India ...
(Date:8/1/2014)... HealthDay Reporter FRIDAY, Aug. 1, ... a time-honored destination for a good cut and conversation. ... be the spot to tackle an often overlooked health concern: ... partnership, the U.S. Centers for Disease Control and Prevention, together ... help of barbershop staff to both discuss and diagnose high ...
(Date:8/1/2014)... 2014 Over the past five ... innovative technologies that have enabled cosmetic dentists to ... color. Moreover, the burgeoning elderly population has stimulated ... ailments. Due to long-term use of medications, which ... demanded dental fillings, veneers and implants. As more ...
Breaking Medicine News(10 mins):Health News:Expert Offers School Bus Safety Tips 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... also available in Chinese ., , ... side effects of chemotherapy in cancer patients by stimulating ... in mice suggests., The research will appear in the ... which is published by AAAS, the nonprofit science ...
... A paper by Indiana University-Purdue University Indianapolis ... to improve identification of breast cancer tissue by ... scientific paper in the "bioinformatics and biomedical applications ... The best scientific paper award ...
... WEDNESDAY, Aug. 18 (HealthDay News) -- With their enticing cool ... the most controversial products made by the tobacco industry. ... of smokers aged 12 to 17 using menthol cigarettes, according ... Most black teenaged smokers -- and 82.7 percent of black ...
... Center in Israel have determined that the use ... outcome for patients undergoing percutaneous coronary intervention (PCI), ... appear in the September issue of Catheterization ... Wiley-Blackwell on behalf of The Society for Cardiovascular ...
... Aug. 19, 2010 A pediatric urologist at UT ... for young girls who have absent or malformed vaginas, ... Unknown causes and certain genetic disorders can cause ... other birth defects that can accompany the vaginal problems, ...
... To improve the quality of HIV care and treatment ... and monitoring of antiretroviral therapy should be adopted uniformly, according ... The work group,s study results appear in the current ... study shows how national HIV quality performance measures were developed, ...
Cached Medicine News:Health News:Ancient Chinese medicine may help chemotherapy patients 2Health News:FDA Mulling Ban on Menthol Cigarettes 2Health News:FDA Mulling Ban on Menthol Cigarettes 3Health News:FDA Mulling Ban on Menthol Cigarettes 4Health News:Drug-eluting stents confirmed safe, effective for long-term use 2Health News:Pediatric urologist performs innovative procedure for girls with rare vaginal defects 2Health News:Uniform, national measures should define HIV/AIDS care 2
... Parathyroid hormone (PTH) is synthesized ... secreted in response to decreased extracellular ... enhancing bone resorption and decreasing calcium ... into the circulation, intact PTH is ...
... the adrenal cortex and, to a lesser ... a precursor in testosterone and estrogen synthesis, ... at ~10% that of testosterone [1]. However, ... women, DHEA is an important androgen as ...
... steroid, is one of the most potent ... testosterone is secreted primarily by the testes ... peripheral conversion of androstenedione [2]. In adult ... 50% of serum testosterone is derived from ...
... Thyroxine (T4) is the primary active ... the thyroid gland [1]. T4 is synthesized ... iodide trapping by the follicular cells, (ii) ... substrate leading to formation of 3-monoiodotyrosine and ...
Medicine Products: